Launch week offerEnds in00h00m00s

annual Promonthly Pro

Anssi Auvinen

University of Tampere

Finland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Finland Professors in Medical Imaging Medical Imaging professors in Finland

Articles (46)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (29)

Teemu J. Murtola

FINLAND

View details

Javier Bracchiglione Pérez

Institut de Recerca Sant Pau

SPAIN

View details

Eric J. Chow

Seattle Children's Hospital

UNITED STATES

View details

Jack A. Schalken

NETHERLANDS

View details

Alex Asiimwe

UNITED KINGDOM

View details

Jeremy M. Schraw

Voluntary Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Giuseppe Gorini

Institute for Cancer Research, Prevention and Clinical Network-ISPRO

ITALY

View details

David R Baldwin

University of Nottingham

UNITED KINGDOM

View details

Joachim Schuz

Head of Section

International Agency for Research on Cancer

FRANCE

View details

Jari Haukka

Sr. University Lecturer

University of Helsinki

FINLAND

View details

Hajo Zeeb

Head

Leibniz Institute for Prevention Research and Epidemiology - BIPS

GERMANY

View details

Susan Evans Axelsson

Senior Scientist

Lund University

SWEDEN

View details

Jaakko Nevalainen

Head, Professor of Biostatistics

University of Tampere

FINLAND

View details

Julia E. Heck

Professor

University of North Texas

UNITED STATES

View details

Aino Siltari

University of Helsinki

FINLAND

View details

Luis Llanes

Associated Professor

Universidad Francisco de Vitoria

SPAIN

View details

Ana M. Mora

University of California

UNITED STATES

View details

Giorgio Tettamanti

Karolinska Institutet

SWEDEN

View details

Jonne Åkerla

University of Tampere

FINLAND

View details

Maria Feychting

Karolinska Institutet

SWEDEN

View details

Kimmo Taari

University of Helsinki

FINLAND

View details

Atte Nikkilä

University of Tampere

FINLAND

View details

Ilkka Pietilä

Associate professor

University of Helsinki

FINLAND

View details

Ola Bratt

Professor

University of Gothenburg

SWEDEN

View details

Sebastiaan Remmers

Erasmus University Rotterdam

NETHERLANDS

View details

Mika Helminen

University of Tampere

FINLAND

View details

Antti Rannikko

University of Helsinki

FINLAND

View details

Jani Raitanen

University of Tampere

FINLAND

View details

John D. Boice

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anssi Auvinen

Research Interests

Make your next move.

Explore related searches

Articles (46)

Diabetes and Cancer‐Specific Survival: A Nationwide Population‐Based Cohort Study Across Multiple Cancer Sites

The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding global collaboration in pediatric cancer etiology research.

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program

Maternal smoking and risk of childhood cancer: a report from the Childhood Cancer and Leukemia International Consortium

Comparison of the Swedish and Finnish Centers in the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Population impact of PSA screening

Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022

Mortality and cause of death in childhood onset epilepsy

European Study of Prostate Cancer Screening - 23-Year Follow-up

Estimation of New Cancers Attributable to Alcohol, Tobacco, and Human Papillomavirus Infection in Edo State, Nigeria

European Code Against Cancer, 5th edition

Association of Childhood Acute Leukemia With Autoimmune Diseases

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Faces of inequality

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021

Do differences in secondary treatment explain mortality impact of prostate cancer screening?

Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Cancer risk due to ingestion of naturally occurring radionuclides through drinking water

Searching for a serial killer on a hospital ward

Childhood acute leukemia and type 1 diabetes in children

Clustering of childhood acute leukemia in Finland

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml

Method of detection, determinants and subsequent treatments for breast, cervical and prostate cancers in Edo–Benin, Nigeria

Risk factors for low-risk prostate cancer

European Study of Prostate Cancer Screening

SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients

Regression calibration of self-reported mobile phone use to optimize quantitative risk estimation in the COSMOS study

Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom

Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study

Education and employment among patients with childhood-onset epilepsy in adulthood: A population-based cohort study

Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI—A Comparison with the General Population

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated bother

Do LUTS Predict Mortality? An Analysis Using Random Forest Algorithms

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

Missingness in the expanded prostate cancer index short form (EPIC-26) – prevalence, patterns, and explanatory factors

First diagnostic results from Gothenburg-2 screening trial

Dual direction associations between common autoimmune diseases and leukemia among children and young adults

Residential mobility and childhood inflammatory bowel disease

Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL

Cancer incidence among Chernobyl cleanup workers from Estonia: A 34‐year follow‐up

Increased cardiovascular disease risk after exposure to low dose radiation

Suicide and other causes of death among Chernobyl cleanup workers from Estonia, 1986 − 2020: an update

Collaborators (29)

Teemu J. Murtola

Javier Bracchiglione Pérez

Eric J. Chow

Jack A. Schalken

Alex Asiimwe

Jeremy M. Schraw

Giuseppe Gorini

David R Baldwin

Joachim Schuz

Jari Haukka

Hajo Zeeb

Susan Evans Axelsson

Jaakko Nevalainen

Julia E. Heck

Aino Siltari

Luis Llanes

Ana M. Mora

Giorgio Tettamanti

Jonne Åkerla

Maria Feychting

Kimmo Taari

Atte Nikkilä

Ilkka Pietilä

Ola Bratt

Sebastiaan Remmers

Mika Helminen

Antti Rannikko

Jani Raitanen